Vasomotor symptoms and heart failure in midlife women of the CARDIA study

Menopause. 2026 Mar 3. doi: 10.1097/GME.0000000000002766. Online ahead of print.ABSTRACTOBJECTIVE: Current evidence has demonstrated associations of vasomotor symptoms (VMS) with cardiovascular disease risk factors and subclinical atherosclerosis. However, the relationship between VMS and incident h

I Imo A Ebong

7-T Potassium (39K) MRI to Assess Muscle K+ Depletion in Primary Aldosteronism

Background Although 98% of potassium (K^(+)) resides intracellularly, current clinical diagnostics assess only extracellular K^(+) concentrations. Noninvasive imaging of tissue K^(+) distribution could provide novel insights into pathophysiologic processes in diseases such as primary aldosteronism (

C Christoph Kopp

Circulating Exosomal MicroRNAs as Potential Biomarkers for Pulmonary Embolism

Clin Appl Thromb Hemost. 2026 Jan-Dec;32:10760296251407689. doi: 10.1177/10760296251407689. Epub 2026 Mar 3.ABSTRACTPulmonary embolism (PE) is difficult to diagnose due to nonspecific symptomatology and lack of accurate diagnostic tools. PE can be categorized into low-risk, submassive, and massive b

C Chongyu Zhang

Short- and Long-term Metabolic Exposure Data as Predicators of Coronary Microvascular Dysfunction in a Positron Emission Tomography Myocardial Perfusion Imaging (PET-MPI) Cohort with Near Concurrent Angiography

Biomarkers. 2026 Mar 3:1-8. doi: 10.1080/1354750X.2026.2639408. Online ahead of print.ABSTRACTBackgroundCoronary microvascular disease (CMD) is defined by impaired myocardial stress flow reactivity and is associated with worse cardiovascular outcomes. Studying CMD is complicated by the overlap of it

J Joseph Van Galen

Lipoprotein (a): A biomarker of cardiovascular risk detectable in childhood

Arch Argent Pediatr. 2026 Mar 5:e202510892. doi: 10.5546/aap.2025-10892.eng. Online ahead of print.ABSTRACTLipoprotein (a) [Lp(a)] is a lipoprotein similar to low-density lipoprotein (LDL), which binds to a characteristic component: apolipoprotein (a). The plasma Lp(a) level is mainly determined by

W Walter Masson